Design novel dual agonists for treating type-2 diabetes by targeting peroxisome proliferator-activated receptors with core hopping approach
about
Identification of Damaging nsSNVs in HumanERCC2 Gene.The discovery of a novel compound with potent antitumor activity: virtual screening, synthesis, biological evaluation and preliminary mechanism study.Identification of novel multitargeted PPARα/γ/δ pan agonists by core hopping of rosiglitazoneRole of peroxisome proliferator-activated receptors gene polymorphisms in type 2 diabetes and metabolic syndrome.Design, synthesis, biological activity and molecular dynamics studies of specific protein tyrosine phosphatase 1B inhibitors over SHP-2iNR-Drug: predicting the interaction of drugs with nuclear receptors in cellular networking.Peroxisome proliferator-activated receptor α ligands and modulators from dietary compounds: Types, screening methods and functions.Find novel dual-agonist drugs for treating type 2 diabetes by means of cheminformatics.Small molecular floribundiquinone B derived from medicinal plants inhibits acetylcholinesterase activity.Finding a Potential Dipeptidyl Peptidase-4 (DPP-4) Inhibitor for Type-2 Diabetes Treatment Based on Molecular Docking, Pharmacophore Generation, and Molecular Dynamics Simulation.Bioassay directed isolation and biological evaluation of compounds isolated from Rubus fairholmianus Gard.Molecular docking of Glyceroneogenesis pathway intermediates with Peroxisome Proliferator- Activated Receptor-Alpha (PPAR-α).Design and synthesis of imidazolidine-2,4-dione derivatives as selective inhibitors by targeting protein tyrosine phosphatase-1B over T-cell protein tyrosine phosphatase.The discovery of a novel and selective inhibitor of PTP1B over TCPTP: 3D QSAR pharmacophore modeling, virtual screening, synthesis, and biological evaluation.A Comprehensive In Silico Method to Study the QSTR of the Aconitine Alkaloids for Designing Novel DrugsSAR and Computer-Aided Drug Design Approaches in the Discovery of Peroxisome Proliferator-Activated ReceptorγActivators: A Perspective
P2860
Q30386998-E50A8A89-4123-4256-B866-D9E1AA340D55Q33648593-E31C3AC0-32C6-4C52-BD9C-5CDD94493FB1Q34511474-FAF6F804-CE51-4F40-BF50-A3CD6F307299Q35613936-5A0590DA-F248-4A0F-91EF-7254DB6A80D1Q37007402-AAA42434-C82B-44AD-ABFF-708CD5FB83F9Q37684124-064F6450-7B3E-46BC-AD24-F5EB6F46E0C1Q39013200-06437D25-8E64-4FAF-B473-8DAFEB2DEE1BQ39771912-617C1D43-96A6-4AB8-A8F3-8000877CA578Q41342817-9F78770B-633C-4502-A36D-8C5C9BB23972Q41812639-4A0BAA45-3F59-4E6F-A752-E395C2CA3E65Q41834802-5717894A-6490-426D-8EB7-0FB1A0A08B4BQ41993601-E17FA7B7-7D57-4418-9D3F-2DDDF1EC9D65Q48019500-FEC63161-DD99-44EE-A6D7-85C7428545F8Q51759061-28A7C72E-F494-48FC-85DE-3E69DFC32078Q58696412-5CE27066-A4D9-4249-A0BC-3A4008AAB396Q58919671-26B4E038-B0E3-4170-91BC-AED671D09C95
P2860
Design novel dual agonists for treating type-2 diabetes by targeting peroxisome proliferator-activated receptors with core hopping approach
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Design novel dual agonists for ...... ors with core hopping approach
@ast
Design novel dual agonists for ...... ors with core hopping approach
@en
Design novel dual agonists for ...... ors with core hopping approach
@nl
type
label
Design novel dual agonists for ...... ors with core hopping approach
@ast
Design novel dual agonists for ...... ors with core hopping approach
@en
Design novel dual agonists for ...... ors with core hopping approach
@nl
prefLabel
Design novel dual agonists for ...... ors with core hopping approach
@ast
Design novel dual agonists for ...... ors with core hopping approach
@en
Design novel dual agonists for ...... ors with core hopping approach
@nl
P2093
P2860
P3181
P1433
P1476
Design novel dual agonists for ...... ors with core hopping approach
@en
P2093
Run-Ling Wang
Shu-Qing Wang
Wei-Ren Xu
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0038546
P407
P577
2012-01-01T00:00:00Z